Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter de Boer

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Biology of Reproduction|December 24, 2010
Are there benefits from having two genetic fathers?Peter de Boer, Marieke de Vries
Biology Open|December 6, 2012
Chromatin remodelling initiation during human spermiogenesisMarieke De Vries, Liliana Ramos, Zjwan Housein, et al.
Mutation Research|September 23, 2008
Role of H2AX in DNA damage response and human cancersNiloo Srivastava, Sailesh Gochhait, Peter de Boer, et al.
Protein and Peptide Letters|March 30, 2011
Protamine 2 precursors and processingSara de Mateo, Liliana Ramos, Peter de Boer, et al.
Human Molecular Genetics|March 21, 2008
DNA double-strand break repair in parental chromatin of mouse zygotes, the first cell cycle as an origin of de novo mutationAlwin Derijck, Godfried van der Heijden, Maud Giele, et al.
Neuroimage. Clinical|July 14, 2018
Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control networkFelix Mueller, Francesco Musso, Markus London, et al.
Psychopharmacology|April 18, 2013
Effects of nicotine withdrawal on cognition in a clinical trial settingKeith A Wesnes, Chris J Edgar, Iva Kezic, et al.
Journal of Clinical Pharmacology|May 2, 2003
Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human studyDolly A Parasrampuria, Peter de Boer, Daksha Desai-Krieger, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2018
Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effectsPeter D van der Ark, Georg Golor, Luc van Nueten, et al.
Intensive Care Medicine|October 31, 2012
Fatal strongyloidiasis in an immunocompromised HTLV-I infected patientMichiel Peter de Boer, Christianne Bethlem-Schaap, Stephen de Jager, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Biology of Reproduction|December 24, 2010
Are there benefits from having two genetic fathers?Peter de Boer, Marieke de Vries
Biology Open|December 6, 2012
Chromatin remodelling initiation during human spermiogenesisMarieke De Vries, Liliana Ramos, Zjwan Housein, et al.
Mutation Research|September 23, 2008
Role of H2AX in DNA damage response and human cancersNiloo Srivastava, Sailesh Gochhait, Peter de Boer, et al.
Protein and Peptide Letters|March 30, 2011
Protamine 2 precursors and processingSara de Mateo, Liliana Ramos, Peter de Boer, et al.
Human Molecular Genetics|March 21, 2008
DNA double-strand break repair in parental chromatin of mouse zygotes, the first cell cycle as an origin of de novo mutationAlwin Derijck, Godfried van der Heijden, Maud Giele, et al.
Neuroimage. Clinical|July 14, 2018
Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control networkFelix Mueller, Francesco Musso, Markus London, et al.
Psychopharmacology|April 18, 2013
Effects of nicotine withdrawal on cognition in a clinical trial settingKeith A Wesnes, Chris J Edgar, Iva Kezic, et al.
Journal of Clinical Pharmacology|May 2, 2003
Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human studyDolly A Parasrampuria, Peter de Boer, Daksha Desai-Krieger, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2018
Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effectsPeter D van der Ark, Georg Golor, Luc van Nueten, et al.
Intensive Care Medicine|October 31, 2012
Fatal strongyloidiasis in an immunocompromised HTLV-I infected patientMichiel Peter de Boer, Christianne Bethlem-Schaap, Stephen de Jager, et al.
Pageof 9